Scarica l'app Stockscreener
22.87
0.95%
-0.22
Dopo l'orario di chiusura:
22.88
0.010
+0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom - Insider Monkey
Pfizer Dissolves Share Stake In Akero Therapeutics - marketscreener.com
Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order. - Barron's
Should Value Investors Buy Pfizer (PFE) Stock? - Nasdaq
Drug Price Regulations: Is Pfizer Stock A Buy Or Sell? - Forbes
Pfizer And Drug Pricing: Should You Invest Now? - Trefis
Saudi Arabia Active Pharmaceutical Ingredients Market Forecasts & Opportunities Report 2024-2025 & 2030 Featuring Pfizer, Aurobindo Pharma, Novartis, BASF, Viatris, and Novo Nordisk - GlobeNewswire Inc.
What has Trump said about cutting drug prices? - marketscreener.com
Pfizer, Merck, Johnson & Johnson to lose billions to Trump's latest executive order - TheStreet
Pfizer, Eli Lilly, Merck Stock Turns Around on Trump Drug Pricing Executive Order - Barron's
US Pharma stocks Pfizer, Amgen, Merck & Co. jump over 3% on early Wall Street after Trump cut drug prices - Mint
Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW - TradingView
Shareholders Will Be Pleased With The Quality of Pfizer's (NYSE:PFE) Earnings - Yahoo Finance
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket - Benzinga
Faruqi & Faruqi Reminds Cerevel Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - GlobeNewswire Inc.
Aminoglycosides Market Growth, Trends & Forecast 2025 | Top key - openPR.com
Investors three-year losses continue as Pfizer (NYSE:PFE) dips a further 7.9% this week, earnings continue to decline - Yahoo Finance
Pfizer’s $15 Billion War Chest: What Will They Buy After the Danuglipron Failure? - Smartkarma
Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond? - Insider Monkey
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
Is Pfizer Stock A Buy Or A Sell On Its Massive Savings Plan? - Investor's Business Daily
Are Your Mega-High Stock Dividends Safe? - TradingView
Pfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy? - 24/7 Wall St.
Pfizer (PFE) Just Overtook the 20-Day Moving Average - Yahoo Finance
Was Jim Cramer Right About Pfizer (PFE)? - Yahoo Finance
Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment - Endpoints News
Layoff Tracker: Shape, Vor Cut Workforces - BioSpace
If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now? - Yahoo Finance
Chronic Pelvic Pain Treatment Market Is Booming Worldwide 2025-2032 | Pfizer Inc., Johnson & Johnson, AbbVie Inc. - openPR.com
Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug - Bloomberg Law News
Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Pfizer Inc. (NYSE:PFE) Q1 2025 Earnings Call Transcript - MSN
The Mindfulness of Medicine Development: How Scientists Are Driving the Next Wave of Medical Innovations - Pfizer
Jim Cramer on Pfizer (PFE): “Trying Big Targets, but New Wins Still Elusive” - Insider Monkey
US FDA advisers to discuss COVID-19 vaccine recommendations on May 22 - marketscreener.com
Pfizer (PFE) Awaits FDA Panel Review of Cancer Drug Combination - GuruFocus
Pfizer, J&J, Genentech drugs subject of FDA advisory panel meeting this month - Seeking Alpha
Ex-Dividend Reminder: American Electric Power, Pfizer and Tompkins Financial - Nasdaq
Pharma imports to US surged in March as drugmakers look to avoid tariffs - marketscreener.com
Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers. - Barron's
Pfizer (PFE) RSV Vaccine Recommendations Under Review - GuruFocus
Pfizer, GSK RSV shot recommendations under scrutiny from RFK Jr. aidereport - Seeking Alpha
PFE Stock Price: Pfizer Inc Named Top Dividend Stock as Insider Buying Surges, Yield Hits 7.21% - paginasiete.bo
Pfizer Has Unreasonable Whiff Of The Marlboro Man - Seeking Alpha
Pfizer Named Top Dividend Stock With Insider Buying and 7.21% Yield (PFE) - Nasdaq
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics - TradingView
Here's Why We're Wary Of Buying Pfizer's (NYSE:PFE) For Its Upcoming Dividend - simplywall.st
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend - Yahoo Finance
Recombinant Human Endostatin Market Top PlayersPfizer Inc., - openPR.com
April Social Media Round-Up—Webby Award, World Immunization Week, and More - Pfizer
Pfizer Stock Up 5% Following Q1 Results: Time To Buy, Sell Or Hold? - Barchart.com
Analyst recommendations: Amazon, PepsiCo, Linde, Pfizer, Crowdstrike Holdings... - marketscreener.com
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Sirolimus Market Is Booming Worldwide 2025-2032 | Pfizer Inc., Actiza, Zydus Cadila Healthcare Ltd. - openPR.com
Pfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold? - Nasdaq
Anti Suicide Drugs Market Detailed In New Research Report 2025 | - openPR.com
Is Pfizer Inc. (PFE) The Most Profitable Cheap Stock to Buy Now? - Insider Monkey
Is Pfizer Inc.'s (NYSE:PFE) Stock Price Struggling As A Result Of Its Mixed Financials? - Yahoo Finance
West Virginia counties, cities to receive Pfizer settlement checks - WBOY.com
2.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):